Europe’s tentative embrace of agricultural gene editing could revolutionize food production and health in Asia

Credit: Lê Tuấn Hùng  via CC0-1.0
Credit: Lê Tuấn Hùng via CC0-1.0

On June 17, 2026, the European Parliament reached a historic milestone by endorsing New Genomic Techniques (NGTs), sending a powerful global signal that science-based innovation is essential for addressing climate change and strengthening food security.

For Asia, the implications could be profound.

Home to nearly 60% of the world’s population, Asia faces the daunting task of feeding billions while confronting some of the world’s harshest climate impacts. 

Rising temperatures, droughts, floods, salinity intrusion, emerging pests, and global crises are placing immense pressure on agricultural systems. 

According to the International Food Policy Research Institute (IFPRI), countries such as Bangladesh, India, and Pakistan remain highly vulnerable to geopolitical shocks because of their dependence on imported fertilizers and natural gas from the Gulf region. The ongoing Iran conflict, the latest disruption to global fertilizer markets, underscores this vulnerability.

Against this backdrop, NGTs offer a promising tool for developing climate-resilient crops, reducing reliance on pesticides and fertilizers, and strengthening food security, particularly for smallholder farmers.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

For decades, the European Union maintained some of the world’s strictest regulations on agricultural biotechnology, influencing policy-making far beyond Europe. Many countries in Asia and Africa adopted similarly cautious approaches. 

Europe’s endorsement of NGTs therefore marks a significant shift, demonstrating that innovation and environmental sustainability can go hand in hand.

Several Asian countries are already moving ahead. China has made gene editing a national priority to enhance food security, while Japan has established enabling regulations and commercialized gene-edited foods. 

India is actively exploring genome editing to develop climate-resilient crops, and countries including the Philippines, South Korea, Singapore, Vietnam, and Bangladesh are advancing research and regulatory reforms.

Yet technological potential alone will not be enough. Historically, biotechnology research has relied heavily on private investment and donor support. 

Today, shrinking research budgets, limited technical expertise, and underinvestment in public research institutions remain major constraints, particularly in developing countries. 

Realizing the benefits of genome editing will require evidence-based policymaking, sustained public investment, and long-term government commitment to translate scientific advances into practical solutions for farmers.

Europe’s decision should not be treated as a blueprint to be followed uncritically. Rather, it should encourage countries such as Bangladesh to engage in evidence-based decision-making and assess how emerging technologies like genome editing can contribute to more resilient, sustainable, and food-secure agricultural systems.

Arif Hossain is Regional Head of Asia, WePlanet International and Executive Director at Farming Future Bangladesh. Find Arif on X @arif4science

A version of this article was originally posted at Dhaka Tribune and has been reposted here with permission. Any reposting should credit the original author and provide links to both the GLP and the original article. Find Dhaka Tribune on X @DhakaTribune



{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-07-09-at-1.09.25-PM
Anti-vaccine myths rattle health care
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Jul-10-2026-12_21_03-PM
Viewpoint: Is there new evidence that the animal deworming drug ivermectin decreases the risk of Covid and cancer? Don’t waste your money.
Picture1
Hiroshima at 81: America’s new nuclear bomb, a buried Iranian target, and a question no one wants to ask
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
leeteam
How Kennedy and his family could pocket millions from Merck’s $50 million vaccine injury settlement that he oversaw
Screenshot-2026-07-30-at-2.30.35-PM
Climate scientists claim conservative activists are promoting ‘lies’ that Europe’s summer heatwaves are far from unusual
Screenshot-2026-07-30-at-3.07.42-PM
Controversy over WNBA star Sophie Cunningham’s comment opposing trans females in women’s sports reinvigorates the culture wars

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.